| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/25/2002 | WO2001090317A3 Beta-galactosidase isolated from a bifidobacterium |
| 04/25/2002 | WO2001088168A3 Mapping molecular interactions in plants with protein fragments complementation assays |
| 04/25/2002 | WO2001088136A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 04/25/2002 | WO2001083791A3 Identification and characterization of a pagoda phenotype (PGD) in plants |
| 04/25/2002 | WO2001083740A3 Splice-region antisense composition and method |
| 04/25/2002 | WO2001081564A3 Method for producing DNA encoding polypeptides that are composed of several sections, and for producing polypeptides by expressing the DNA thus obtained |
| 04/25/2002 | WO2001077348A3 Ketogulonigenium endogenous plasmids |
| 04/25/2002 | WO2001075121A3 16836, a human phospholipase c family member and uses thereof |
| 04/25/2002 | WO2001073073A3 Regulation of human neutral protease-related enzyme |
| 04/25/2002 | WO2001073058A3 33338, a novel human ubiquitin hydrolase-like molecule and uses thereof |
| 04/25/2002 | WO2001068907A3 Stable expression of polymorphous forms of human cytochrome P450 2D6 |
| 04/25/2002 | WO2001068889A3 Method for gene transfection and vaccination through skin using electropermeabilization |
| 04/25/2002 | WO2001068880A3 Estrogen-regulated myo-inositol phosphate synthase: compositions and methods of use |
| 04/25/2002 | WO2001062938A3 Variant galactose oxidase, nucleic acid encoding same, and methods of using same |
| 04/25/2002 | WO2001062927A3 Polypeptides and corresponding polynucleotides for diagnostics and therapeutics |
| 04/25/2002 | WO2001062922A3 Polypeptides and corresponding molecules for disease detection and treatment |
| 04/25/2002 | WO2001062908A3 Chimeric and tcr phage display libraries, chimeric and tcr reagents and methods of use thereof |
| 04/25/2002 | WO2001061041A3 Multiple-site reaction device and method |
| 04/25/2002 | WO2001061015A3 Thermostable chimeric nucleic acid polymerases and uses thereof |
| 04/25/2002 | WO2001061010A3 GTPASE activating proteins |
| 04/25/2002 | WO2001060975A3 Gene disruption methodologies in fungi for drug target discovery |
| 04/25/2002 | WO2001060847A3 avirulent, immunogenic flavivirus chimeras |
| 04/25/2002 | WO2001059102A3 Nucleozymes with endonuclease activity |
| 04/25/2002 | WO2001058940A3 Adenoviral capsid containing chimeric protein IX |
| 04/25/2002 | WO2001055361A3 Recombinant AAV packaging systems |
| 04/25/2002 | WO2001052904A3 Pharmaceutical compositions and methods of treatment based on VEGF antisense oligonucleotides |
| 04/25/2002 | WO2001049112A3 Oocyte vitrification technique |
| 04/25/2002 | WO2001048214A3 METHOD FOR PRODUCING 6-0-α-D-GLUCOPYRANOSYL-D-SORBITE |
| 04/25/2002 | WO2001044476A3 Moss genes from physcomitrella patens encoding proteins involved in the synthesis of carbohydrates |
| 04/25/2002 | WO2001042471A3 Polypeptides and polynucleotides encoding same |
| 04/25/2002 | WO2001040517A3 Evaluating and predicting clinical outcomes by gene expression analysis |
| 04/25/2002 | WO2001038580A3 Nucleic acid probe arrays |
| 04/25/2002 | WO2001031017A3 Plants with a modified flower and seed development |
| 04/25/2002 | WO1999049013A3 Tryptophan biosynthetic enzymes |
| 04/25/2002 | US20020049999 Cotton plants with improved cotton fiber characteristics and method for producing cotton fibers from these cotton plants |
| 04/25/2002 | US20020049998 Cytoplasmic male sterility system production canola hybrids |
| 04/25/2002 | US20020049997 Methods for producing and transforming cassava protoplasts |
| 04/25/2002 | US20020049996 Nucleic acid and amino acid sequences encoding a de novo DNA methyltransferase |
| 04/25/2002 | US20020049995 Nucleic acid encoding GAI gene of arbidopsis thaliana |
| 04/25/2002 | US20020049994 Enzymes involved in very long chain fatty acid (VLCFA) synthesis; plants and cells containing exogenous nucleic acids |
| 04/25/2002 | US20020049993 Maize rhoGTPase-activating protein (rhoGAP) polynucleotides and methods of use |
| 04/25/2002 | US20020049992 When placed upstream of a gene of interest (i.e. heterologous gene), will cause that gene to be expressed at a high level; plants, seeds |
| 04/25/2002 | US20020049989 Transgenic mice containing stefin homolog protease inhibitor gene disruptions |
| 04/25/2002 | US20020049988 Transgenic animals harboring APP allele having swedish mutation |
| 04/25/2002 | US20020049987 Non-human transgenic animals expressing platelet-derived growth factor C (PDGF-C) and uses thereof |
| 04/25/2002 | US20020049986 High throughput genetic screening of lipid and cholesterol processing using fluorescent compounds |
| 04/25/2002 | US20020049545 Amino acid frame indication system, method for amino acid frame indication, and recording medium |
| 04/25/2002 | US20020049544 Image analysis for phenotyping sets of mutant cells |
| 04/25/2002 | US20020049543 Method for displaying gene experiment data |
| 04/25/2002 | US20020049313 Method for introducing foreign material into higher eukaryotic cells |
| 04/25/2002 | US20020049312 Noel human thrombospondin-like proteins and polynucleotides encoding the same |
| 04/25/2002 | US20020049306 Differentiation-suppressive polypeptide |
| 04/25/2002 | US20020049302 Purification of preferential lymphocytes; incubate modulator with cells, detect lymphocytes expressing detectable markers |
| 04/25/2002 | US20020049180 KIAA0175 inhibitor is selected from the group consisting of an anti-sense molecule, a ribozyme, an antibody, an antibody fragment, a protein, a polypeptide and a small molecule. |
| 04/25/2002 | US20020049177 Detecting an aberrant level or bioactivity of or screening for a Wnt pathway component or a frizzled related protein gene product |
| 04/25/2002 | US20020049175 Decreasing viral replication in cells by decreasing levels of functional cellular protease; exposing the cells to a compound which decreases cellular protease gene expression. |
| 04/25/2002 | US20020049174 First region is available for hybridization and the second region is temporarily masked. |
| 04/25/2002 | US20020049173 Binding to said target an antisense compound which is specifically hybridizable with said mRNA target and which does not elicit cleavage of the mRNA target upon binding |
| 04/25/2002 | US20020049154 Bioconjugates and delivery of bioactive agents |
| 04/25/2002 | US20020049151 Therapeutic approaches to diseases by suppression of the NURR subfamily of nuclear transcription factors |
| 04/25/2002 | US20020048816 Genetically engineered cell; for use as a vaccine; for use in screening polypeptides and antigens; for use as a support for immobilizing an enzyme, peptide or antigen |
| 04/25/2002 | US20020048814 Reducing gene expression in eukaryotic cells; obtain cells, incubate with modulator, monitor cells for decreased gene expression |
| 04/25/2002 | US20020048811 Polypeptide for use in in situ detection and drug screening |
| 04/25/2002 | US20020048809 Capillary array-based sample screening |
| 04/25/2002 | US20020048805 Feline immunodeficiency virus gene therapy vectors |
| 04/25/2002 | US20020048804 Human translation protein; for use in the treatment of cancer |
| 04/25/2002 | US20020048803 MAP kinase phosphatase mutant |
| 04/25/2002 | US20020048802 Enzymatic polypeptide for use generation of single stranded nucleotide sequences |
| 04/25/2002 | US20020048801 Peptide with enzymatic activity; for use as diagnostic tools in detecting cancer and cardiovascular and liver disorders |
| 04/25/2002 | US20020048800 Myosin-like gene expressed in human heart and muscle |
| 04/25/2002 | US20020048799 Insecticidal protein fragments |
| 04/25/2002 | US20020048794 Polypeptides for use in the diagnosis and treatment of skin disorders, cancer, vision and demyelination defects, inflammation, glomerculonephritis, Kaposi's sarcoma, angiogenesis, sarcoidosis, osteoarthritis and aneurysm |
| 04/25/2002 | US20020048792 Methods and materials for regulated production of proteins |
| 04/25/2002 | US20020048791 Nucleotide sequences coding preferential polypeptides; for use in the treatment of dietetics, diabetes, anxiety, hypertension, drug dependence, congestive heart failure, cardiovascular disorders, tumors and nervous system disorders |
| 04/25/2002 | US20020048790 Nucleotide sequences coding binding protein for use in the prevention of infections; bactericides |
| 04/25/2002 | US20020048788 FtsA |
| 04/25/2002 | US20020048786 Nucleotide sequences for use in the treatment of infections, arthritis, karposi's sarcoma, allergies, asthma, nervous system and autoimmune diseases |
| 04/25/2002 | US20020048785 Novel polypeptides within the tumor necrosis factor receptor superfamily and uses therefor |
| 04/25/2002 | US20020048784 Prostatic growth factor |
| 04/25/2002 | US20020048782 Pyk2 related products and methods |
| 04/25/2002 | US20020048781 Direct production of desacetylcephalosporin C |
| 04/25/2002 | US20020048778 Particle for use in detection of protein binding positions; antitumor agents |
| 04/25/2002 | US20020048777 Nucleotide sequences for use in therapy, monitoring and screning preferential tumors |
| 04/25/2002 | US20020048770 Electrospraying solutions of substances for mass fabrication of chips and libraries |
| 04/25/2002 | US20020048769 Protein-protein interactions in neurodegenerative disorders |
| 04/25/2002 | US20020048767 Detecting genomic position of preferential genes; obtain nucleotide sequences, incubate with probes, determine distance, positioning and size of probe in genome |
| 04/25/2002 | US20020048765 Apparatus for use as diagnostic tool in drug screening, environmental monitoring and forensic analysis |
| 04/25/2002 | US20020048764 Human PEM as a target for birth contol and treatment of Alzheimer's disease |
| 04/25/2002 | US20020048763 Nucleotide sequences for use in the detection of transcription patterns in preferential tissues |
| 04/25/2002 | US20020048762 Hybridization probes derived from the spacer region between the 16S and 23S rRNA genes for the detection of non-viral microorganisms |
| 04/25/2002 | US20020048761 Molecular cloning using rolling circle amplification |
| 04/25/2002 | US20020048759 Compositions and methods for the therapy and diagnosis of ovarian and endometrial cancer |
| 04/25/2002 | US20020048758 Carrier for gene detection and its use for detecting validity of interferon therapy |
| 04/25/2002 | US20020048757 Simple and quick method for determining the nucleotide sequence of a mitochondrial 21S ribosomal RNA gene of yeast belonging to Saccharomyces cerevisiae |
| 04/25/2002 | US20020048753 Utiliztion of probes for sequence determination; obtain sample, generate probes, mix, hybridize, amplify nucleotide sequences, separate nucleotide sequences by electrophoresis, monitor and compare electrophoretic patterns |
| 04/25/2002 | US20020048748 Controlling human lymphocyte leukemia/lymphoma viruses immunodeficiency virus; obtain human, administer viricide and interleukin, monitor human for adjust in viral activity |
| 04/25/2002 | US20020048578 Modified version of a therapeutic antibody with affinity for a cell-surface antigen; capable of inducing immunological tolerance to the therapeutic antibody |
| 04/25/2002 | US20020048576 Enzyme that cleaves a linkage that effects release of a cell-surface protein or carbohydrate and a physiologically acceptable carrier for said enzyme; form suitable for oral administration. |
| 04/25/2002 | US20020048574 50090, a novel human hydratase and uses thereof |
| 04/25/2002 | US20020048573 Lytic enzymes useful for treating fungal infections |